These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19663632)

  • 21. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
    Charman WN; Porter CJ; Mithani S; Dressman JB
    J Pharm Sci; 1997 Mar; 86(3):269-82. PubMed ID: 9050793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of food intake on presystemic clearance of drugs.
    Melander A; McLean A
    Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular biological methods for characterizing drug-metabolizing enzymes in hepatic and extrahepatic tissues.
    Friedberg T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(2):61-9. PubMed ID: 9603656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytochrome P450 enzymes: ubiquitous "receptors" for drugs.
    LaBella FS
    Can J Physiol Pharmacol; 1991 Aug; 69(8):1129-32. PubMed ID: 1664291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of pharmacokinetic drug-drug interactions].
    Levêque D; Lemachatti J; Nivoix Y; Coliat P; Santucci R; Ubeaud-Séquier G; Beretz L; Vinzio S
    Rev Med Interne; 2010 Feb; 31(2):170-9. PubMed ID: 19740579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of nano-laminated coatings to control bioavailability of lipophilic food components.
    McClements DJ
    J Food Sci; 2010; 75(1):R30-42. PubMed ID: 20492193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of short and medium chain fatty acids on absorption of lipophilic drugs from perfused rat intestine.
    Grisafe JA; Hayton WL
    J Pharm Sci; 1978 Sep; 67(9):1211-5. PubMed ID: 690822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids in the Stomach - Implications for the Evaluation of Food Effects on Oral Drug Absorption.
    Koziolek M; Carrière F; Porter CJH
    Pharm Res; 2018 Feb; 35(3):55. PubMed ID: 29423732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presystemic drug elimination.
    Routledge PA; Shand DG
    Annu Rev Pharmacol Toxicol; 1979; 19():447-68. PubMed ID: 378106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
    Bernkop-Schnürch A; Schmitz T
    Curr Drug Metab; 2007 Jun; 8(5):509-17. PubMed ID: 17584022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acids as therapeutic auxiliaries for oral and parenteral formulations.
    Hackett MJ; Zaro JL; Shen WC; Guley PC; Cho MJ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1331-9. PubMed ID: 22921839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What can the use of unmetabolizable lipophilic compounds tell about the importance of drug metabolism?
    Bickel MH
    Drug Metab Rev; 1989; 20(2-4):441-7. PubMed ID: 2509182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of food on the presystemic metabolism of drugs.
    Melander A; Lalka D; McLean A
    Pharmacol Ther; 1988; 38(2):253-67. PubMed ID: 3054941
    [No Abstract]   [Full Text] [Related]  

  • 35. Dietary lipids and pathology of nervous system membranes.
    Confaloni AM; D'Urso D; Salvati S; Serlupi Crescenzi G
    Ann Ist Super Sanita; 1988; 24(1):171-7. PubMed ID: 3289438
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biologocally active peptides in metabolism regulation. Peptons, peptides, amino acids, fatty acids, lipoproteins, lipids, and the effect of nutriceuticals.].
    Aripovsky AV; Titov VN
    Klin Lab Diagn; 2019; 64(1):14-23. PubMed ID: 30912879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents.
    Counsell RE; Pohland RC
    J Med Chem; 1982 Oct; 25(10):1115-20. PubMed ID: 6754931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Butazolidine inhibition of the enzymatic decomposition of drugs].
    PULVER R
    Arch Int Pharmacodyn Ther; 1954 Aug; 98(4):437-42. PubMed ID: 13208335
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymatic metabolism of drugs and other foreign compounds.
    BRODIE BB; GILLETTE JR; LA DU BN
    Annu Rev Biochem; 1958; 27(3):427-54. PubMed ID: 13571940
    [No Abstract]   [Full Text] [Related]  

  • 40. Frontiers in Lipid and Lipoprotein Research. Conference proceedings. Atlanta, Georgia, 19-21 September 1993.
    Atherosclerosis; 1994 Aug; 108 Suppl():S1-196. PubMed ID: 7802716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.